Components of MMR Vaccine	Excipients Table Allergens Table Components Table
Indication Immunization against mumps, rubella, and especially measles Proprietary Name MMR II Manufacturers Merck Viability Live, attenuated Microorganism Measles, Mumps, Rubella Approved Ages 12 months and older Dose 0.5 mL Route Subcutaneous Dose form Powder Appearance When reconstituted, clear yellow Concentration (per 0.5 mL) Measles, ≥ 1000 TCID50 Mumps, 12,500 TCID50 Rubella, 1000 TCID50 Excipients Sorbitol, 14.5 mg Sodium phosphate, sucrose, 1.9 mg Sodium chloride, hydrolyzed gelatin, 14.5 mg Human albumin, 0.3 mg Fetal bovine serum, <1 ppm Other buffer and media ingredients Neomycin, 25 mcg  Adjuvants None Allergens Residual egg proteins, Neomycin, 25 mcg Preservatives None Media Measles and Mumps, Chicken-embryo cell culture, Medium 199 Rubella, Human-diploid WI-38 cell culture, Minimum Essential Medium Packaging Single-dose vials + diluent vials Routine Storage -50°C - +8°C Package Insert Date Dec 2010 updated January 2012
This page was last updated on February 08, 2012 © 2012 Institute for Vaccine Safety